Malme, K.B.; Stene-Johansen, K.; Klundby, I.; Backe, Ø.; Foshaug, T.; Greve, M.H.; Pihl, C.M.; Finbråten, A.-K.; Dalgard, O.; Midgard, H.
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. Viruses 2024, 16, 858.
https://doi.org/10.3390/v16060858
AMA Style
Malme KB, Stene-Johansen K, Klundby I, Backe Ø, Foshaug T, Greve MH, Pihl CM, Finbråten A-K, Dalgard O, Midgard H.
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. Viruses. 2024; 16(6):858.
https://doi.org/10.3390/v16060858
Chicago/Turabian Style
Malme, Kristian Braathen, Kathrine Stene-Johansen, Ingvild Klundby, Øystein Backe, Tarjei Foshaug, Maria Helseth Greve, Charlotte Meinich Pihl, Ane-Kristine Finbråten, Olav Dalgard, and Håvard Midgard.
2024. "Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial" Viruses 16, no. 6: 858.
https://doi.org/10.3390/v16060858
APA Style
Malme, K. B., Stene-Johansen, K., Klundby, I., Backe, Ø., Foshaug, T., Greve, M. H., Pihl, C. M., Finbråten, A.-K., Dalgard, O., & Midgard, H.
(2024). Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. Viruses, 16(6), 858.
https://doi.org/10.3390/v16060858